IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc.

Core Insights - iRhythm Technologies, Inc. is under investigation by Kahn Swick & Foti, LLC following a Warning Letter from the FDA regarding non-conformities related to its Zio AT System [1][2] - The company faces a securities class action lawsuit for failing to disclose material information, with the court allowing the case to proceed [3] Group 1: FDA Warning and Compliance Issues - On May 30, 2023, iRhythm disclosed receiving a Warning Letter from the FDA concerning non-conformities in medical device regulations, particularly related to the Zio AT System [2] - The FDA's concerns include deficiencies in marketing and capabilities of the Zio AT device, which may pose undisclosed risks to patients [2] Group 2: Legal Proceedings - Following the FDA warning, iRhythm and its executives were sued in a securities class action lawsuit for not disclosing material information during the Class Period [3] - The court has denied the company's motion to dismiss the lawsuit, allowing it to continue, which raises questions about potential breaches of fiduciary duties by the company's officers and directors [3]